Further evidence for the hepatotoxic potential of metamizole
- PMID: 32696537
- DOI: 10.1111/bcp.14473
Further evidence for the hepatotoxic potential of metamizole
Comment on
-
Liver injury associated with the analgetic drug metamizole.Br J Clin Pharmacol. 2020 Jul;86(7):1248-1250. doi: 10.1111/bcp.14294. Epub 2020 May 12. Br J Clin Pharmacol. 2020. PMID: 32400058 Free PMC article. No abstract available.
References
REFERENCES
-
- Bjornsson ES. Liver injury associated with the analgetic drug metamizole. Br J Clin Pharmacol. 2020;86(7):1248-1250. https://doi.org/10.1111/bcp.14294
-
- Andrade S, Bartels DB, Lange R, Sandford L, Gurwitz J. Safety of metamizole: a systematic review of the literature. J Clin Pharm Ther. 2016;41(5):459-477.
-
- Huber M, Andersohn F, Sarganas G, et al. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin case-control surveillance study. Eur J Clin Pharmacol. 2015;71(2):219-227.
-
- Lutz M. Metamizole (dipyrone) and the liver: a review of the literature. J Clin Pharmacol. 2019;59(11):1433-1442.
-
- Sebode M, Reike-Kunze M, Weidemann S, et al. Metamizole: an underrated agent causing severe idiosyncratic drug-induced liver injury. Br J Clin Pharmacol. 2020;86(7):1406-1415. https://doi.org/10.1111/bcp.14254
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
